| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 55/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Nattokinase |
| Appearance | White Powder |
| CAS No. | 133876-92-3 |
| MF | C20H23BCl2N2O9 |
| MW | 517.12162 |
Nattokinase contains angiotensin-converting enzyme inhibitors that can treat hypertension, so its application in the treatment of hypertension can be further studied. Studies have shown that oral administration can significantly reduce the occurrence of deep vein thrombosis and limb edema. It also plays a role in the prevention and treatment of osteoporosis and diabetes.
Given the miraculous function of nattokinase, many scholars have conducted in-depth development of nattokinase foods and health foods containing nattokinase, using them as a functional food that can treat and prevent cardiovascular and cerebrovascular thrombosis, coronary heart disease, angina pectoris, stroke, Alzheimer's disease, and various common and frequently occurring diseases to explore markets around the world.
Scientific research has shown that nattokinase can effectively clear blood clots in the human body, and has good therapeutic effects on hypertension, aging, stroke, muscle spasms, and cardiovascular and cerebrovascular diseases. Thrombosis is one of the major diseases that seriously endanger human health, such as acute myocardial infarction. There are approximately 15 million thrombotic patients worldwide, and the potential market for thrombolytic drugs is about 2 billion US dollars. The active ingredient in natto, nattokinase, as a new generation of thrombolytic agents or health foods, overcomes the disadvantages of poor oral efficacy, high cost, and multiple complications of thrombolytic drugs, and has extremely attractive and broad prospects.
){kind=link}